論文・総説 - 清水　正樹

分割表示  353 件中 161 - 180 件目  ／  全件表示 >>

  1. Shimizu M, Inoue N, Kuroda M, Mizuta M, Sugimoto N, Kaneda H, Ohta K, Yachie A. Angiopoietin-1 and -2 as markers for disease severity in hemolytic uremic syndrome induced by enterohemorrhagic Escherichia coli. Clinical and experimental nephrology. 2017.02; 21 (1): 76-82. ( PubMed, DOI )

  2. Shimizu Masaki, Inoue Natsumi, Kuroda Mondo, Mizuta Mao, Sugimoto Naotoshi, Kaneda Hisashi, Ohta Kazuhide, Yachie Akihiro. 腸管出血性大腸菌によって誘発された溶血性尿毒症症候群における疾患重症度マーカーとしてのアンジオポエチン-1および2(Angiopoietin-1 and -2 as markers for disease severity in hemolytic uremic syndrome induced by enterohemorrhagic Escherichia coli) Clinical and Experimental Nephrology. 2017.02; 21 (1): 76-82. ( 医中誌 )

  3. Ueno K, Shimizu M, Uchiyama A, Hatasaki K. Fulminant respiratory failure due to progressive metastatic pulmonary calcification with no predisposing factors after successful renal transplantation: A case report. Pediatric transplantation. 2016.12; 20 (8): 1152-1156. ( PubMed, DOI )

  4. Mizuta M, Shimizu M, Inoue N, Kasai K, Nakagishi Y, Takahara T, Hamahira K, Yachie A. Serum ferritin levels as a useful diagnostic marker for the distinction of systemic juvenile idiopathic arthritis and Kawasaki disease. Modern rheumatology. 2016.11; 26 (6): 929-932. ( PubMed, DOI )

  5. Kaneda H, Shimizu M, Ohta K, Ushijima K, Gotoh Y, Satomura K, Nagai T, Fujieda M, Morooka M, Yamada T, Yamada M, Wada N, Takaai M, Hashimoto Y, Uemura O. Population pharmacokinetics of mizoribine in pediatric patients with kidney disease. Clinical and experimental nephrology. 2016.10; 20 (5): 757-763. ( PubMed, DOI )

  6. Inoue N, Sato A, Ikawa Y, Shimizu M, Okajima M, Taniguchi T, Yachie A. Successful treatment of exertional heat stroke using continuous plasma diafiltration. Journal of clinical apheresis. 2016.10; 31 (5): 490-2. ( PubMed, DOI )

  7. Leu H, Sugimoto N, Shimizu M, Toma T, Wada T, Ohta K, Yachie A. Tumor necrosis factor-α modifies the effects of Shiga toxin on glial cells. International immunopharmacology. 2016.09; 38 139-43. ( PubMed, DOI )

  8. Inoue N, Shimizu M, Tsunoda S, Kawano M, Matsumura M, Yachie A. Cytokine profile in adult-onset Still's disease: Comparison with systemic juvenile idiopathic arthritis. Clinical immunology (Orlando, Fla.). 2016.08; 169 8-13. ( PubMed, DOI )

  9. Ueno K, Shimizu M, Kubo T, Igarashi N, Hatasaki K. An infant with nephrolithiasis and renal failure: Answers. Pediatric nephrology (Berlin, Germany). 2016.07; 31 (7): 1083-4. ( PubMed, DOI )

  10. Ueno K, Shimizu M, Kubo T, Igarashi N, Hatasaki K. An infant with nephrolithiasis and renal failure: Questions. Pediatric nephrology (Berlin, Germany). 2016.07; 31 (7): 1081-2. ( PubMed, DOI )

  11. Inoue N, Mizuta M, Shimizu M. Clinical Usefulness of 18F-fluorodeoxyglucose Positron Emission Tomography for Enthesitis-related Arthritis Diagnosis. The Journal of rheumatology. 2016.07; 43 (7): 1434-5. ( PubMed, DOI )

  12. Nakagishi Y, Shimizu M, Kasai K, Miyoshi M, Yachie A. Successful therapy of macrophage activation syndrome with dexamethasone palmitate. Modern rheumatology. 2016.07; 26 (4): 617-20. ( PubMed, DOI )

  13. Shimizu M, Inoue N, Mizuta M, Ikawa Y, Yachie A. Leopard skin appearance of cutaneous polyarteritis nodosa on 18Ffluorodeoxyglucose positron emission tomography. Rheumatology (Oxford, England). 2016.06; 55 (6): 1090. ( PubMed, DOI )

  14. Sawai T, Shimizu M, Sakai T, Yachie A. Tubulointerstitial Nephritis and Uveitis Syndrome Associated With Human Papillomavirus Vaccine. Journal of pediatric ophthalmology and strabismus. 2016.05; 53 (3): 190-1. ( PubMed, DOI )

  15. Tasaki Y, Shimizu M, Inoue N, Mizuta M, Nakagishi Y, Wada T, Yachie A. Disruption of vascular endothelial homeostasis in systemic juvenile idiopathic arthritis-associated macrophage activation syndrome: The dynamic roles of angiopoietin-1 and -2. Cytokine. 2016.04; 80 1-6. ( PubMed, DOI )

  16. Yokoyama K, Shimizu M, Yoshida A. Femoral Agminated Petechiae Associated with Acute Parvovirus B19 Infection. The Pediatric infectious disease journal. 2016.02; 35 (2): 228-9. ( PubMed, DOI )

  17. Tajiri H, Nishi J, Ushijima K, Shimizu T, Ishige T, Shimizu M, Tanaka H, Brooks S. A role for fosfomycin treatment in children for prevention of haemolytic-uraemic syndrome accompanying Shiga toxin-producing Escherichia coli infection. International journal of antimicrobial agents. 2015.11; 46 (5): 586-9. ( PubMed, DOI )

  18. Shimizu M, Nakagishi Y, Inoue N, Mizuta M, Ko G, Saikawa Y, Kubota T, Yamasaki Y, Takei S, Yachie A. Interleukin-18 for predicting the development of macrophage activation syndrome in systemic juvenile idiopathic arthritis. Clinical immunology (Orlando, Fla.). 2015.10; 160 (2): 277-81. ( PubMed, DOI )

  19. Takakura M, Shimizu M, Inoue N, Tasaki Y, Ishikawa S, Ohta K, Yachie A. Iodine-induced non-autoimmune hypothyroidism in a patient with steroid-resistant nephrotic syndrome. Pediatrics international : official journal of the Japan Pediatric Society. 2015.10; 57 (5): 1055-6. ( PubMed, DOI )

  20. Sugimoto N, Leu H, Inoue N, Shimizu M, Toma T, Kuroda M, Saito T, Wada T, Yachie A. The critical role of lipopolysaccharide in the upregulation of aquaporin 4 in glial cells treated with Shiga toxin. Journal of biomedical science. 2015.09; 22 78. ( PubMed, DOI )

< 前のページ - 次のページ >

このページの先頭へ▲